Although the drug is approved only for certain problems, doctors have used it to treat the muscular rigidity seen in various medical conditions including the pain of a muscular condition called myofascial pain syndrome
Long-term effects: Long-term safety of retatrutide at high doses outside of controlled trials is not fully researched
Scenario 3: A user expects 6 doses from a vial but sees 5 in the calculator
SC Injection: 2-3 times per week or as directed by provider
For patients seeking weight loss who request B12 injections, GPs should: Assess for genuine deficiency through appropriate blood tests rather than empirical treatment Provide education about the lack of evidence supporting B12 for weight loss in non-deficient individuals Explore underlying concerns about weight and energy levels, addressing these through appropriate channels Signpost to evidence-based resources such as NHS weight management services according to local pathways Patients should contact their GP if they experience unexplained fatigue, neurological symptoms (numbness, tingling, balance problems), or signs of anaemia (pallor, breathlessness, palpitations), as these may indicate B12 deficiency requiring investigation
